Vascular endothelial growth factor (VEGF), known as a mediator of blood vessel formation and permeability, now gains an essential position in allergic lung responses (pages 1095–1103).
This is a preview of subscription content, log in via an institution to check access.
Deborah Maizels
Patricia Fulkerson and Marc Rothenberg
References
Bach, J.F. N. Engl. J. Med. 347, 911–20 (2002).
Nathan, C. Nature 420, 846–852 (2002).
Umetsu, D.T., McIntire, J.J., Akbari, O., Macaubas, C. & DeKruyff, R.H. Nat. Immunol. 3, 715–720 (2002).
Lee, C.G. et al. Nat. Med. 10, 1095–1103 (2004).
Busse, W.W. & Lemanske, R.F. Jr. N. Engl. J. Med. 344, 350–362 (2001).
Lange, P., Parner, J., Vestbo, J., Schnohr, P. & Jensen, G. N. Engl. J. Med. 339, 1194–1200 (1998).
Hoshino, M., Nakamura, Y. & Hamid, Q.A. J. Allergy Clin. Immunol. 107, 1034–1038 (2001).
Kanazawa, H., Nomura, S. & Yoshikawa, J. Am. J. Respir. Crit. Care Med. 169, 1125–1130 (2004).
Hoshino, M., Takahashi, M. & Aoike, N. J. Allergy Clin. Immunol. 107, 295–301 (2001).
Corne, J. et al. J. Clin. Invest. 106, 783–791 (2000).
Le Cras, T.D. et al. Am. J. Physiol. Lung Cell. Mol. Physiol. 287, L134–L142 (2004).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rothenberg, M. VEGF obstructs the lungs. Nat Med 10, 1041–1042 (2004). https://doi.org/10.1038/nm1004-1041
Issue Date:
DOI: https://doi.org/10.1038/nm1004-1041
- Springer Nature America, Inc.
This article is cited by
-
The relationship between serum levels of angiogenin, bFGF, VEGF, and ocular involvement in patients with Behçet’s disease
Graefe's Archive for Clinical and Experimental Ophthalmology (2013)
-
Asthma Treatment Outcome in Children Is Associated with Vascular Endothelial Growth Factor A (VEGFA) Polymorphisms
Molecular Diagnosis & Therapy (2012)